3 Αποτελέσματα
BACKGROUND
Regulation of levels of various neurochemicals and other chemicals in the central and peripheral nervous system is likely to provide a critical mechanism for the treatment and/or prevention of neurodegenerative and psychiatric diseases in humans.
For purposes of this document,
This is a U.S. national phase Application filed under 35 U.S.C. 371 of PCT/EP2008/007051 A2, filed 28 Aug., 2008 claiming priority benefit from EP Application No. 07016897.6, filed 29 Aug. 2007, the entire content of which is hereby incorporated by reference.
The present invention relates to the use
TECHNICAL FIELD OF THE INVENTION
The present invention relates to novel arylpiperazine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents.
More specifically, the compounds according to the present invention have the property of being selective ligands